Effect of exercise on insulin resistance and adiponectin in colorectal cancer survivors

ISRCTN ISRCTN47234641
DOI https://doi.org/10.1186/ISRCTN47234641
Secondary identifying numbers N/A
Submission date
20/04/2014
Registration date
30/04/2014
Last edited
23/10/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Cancer has become a major public health problem in South Korea. The lifestyle factors are important determinants of colorectal cancer risk. Previous studies have shown a strong association between the level of physical activity and the outcomes of colorectal cancer. However, the effects of exercise on insulin resistance and adipocytokines in colorectal cancer patients still need to be investigated. The aim of this study are to assess the effects of a 12-week home-based exercise intervention on insulin resistance and adiponectin (the hormone produced by fat cells which influences the body’s response to insulin) in colorectal cancer survivors.

Who can participate?
Patients with stage II-III colorectal cancer, who have completed all standard cancer treatment at least 4 weeks earlier but no more than 2 years.

What does the study involve?
Patients are randomly allocated to either the exercise group or the control group.
Exercise group patients will be encouraged to walk more than 10,000 steps per day. They will get exercise DVDs, will record their daily activities and will visit the clinic five times during the 12 weeks. Control group patients will be instructed to continue with their usual daily activities.

What are the possible benefits and risks or participating?
Participants allocated to the exercise group will receive the exercise DVDs, a pedometer, exercise hand outs, and results of clinical tests. There are no known risks to participants.

Where is the study run from?
Severance Hospital, Shinchon, Seoul (South Korea).

When is the study starting and how long is it expected to run for?
Patients will be enrolled in the study between August 2011 and December 2014.

Who is funding the study?
Ministry of Health and Welfare (South Korea)

Who is the main contact?
Professor Justin Jeon
jjeon@yonsei.ac.kr

Contact information

Prof Justin Jeon
Scientific

134 Shinchon-Dong, Seodaemun-Gu, Yonsei University
Seoul
120-749
Korea, South

Email jjeon@yonsei.ac.kr

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffects of 12-week home-based exercise program on insulin resistance and adiponectin in colorectal cancer survivors: a randomized controlled trial
Study objectivesThe 12-week exercise intervention program will decrease fasting insulin resistance and increase adiponectin in colorectal cancer survivors.
Ethics approval(s)Institutional Ethics Review Board at Yonsei University College of Medicine
Health condition(s) or problem(s) studiedStage II to III colorectal cancer survivors
InterventionParticipants will be randomized into either an exercise or usual care group via minimization method.
1. The exercise group will receive a 12-week home-based exercise program. They will be encouraged to walk more than 10,000 steps per day (pedometer will be provided). In addition, patients will be provided with exercise DVDs, which consisted of 30 minutes exercise using their own body weight, to be performed at home daily. Following each exercise session, participants will complete their exercise log, recording the daily steps, type of exercise and duration. Exercise group participants will visit the clinic three times during 6 weeks. They will have two exercise education sessions, and the exercise trainer will make sure that patients are able to perform the exercise properly.
2. Participants in the control group will be instructed to continue with their usual daily activities.
Intervention typeOther
Primary outcome measure1. Level of fasting insulin will be measured by a chemiluminescence immunoassay
2. Adiponectin levels will be measured by an enzyme immunoassay kit
3. Insulin resistance will be estimated using the homeostatic model assessment of insulin resistance (HOMA-IR) index
Secondary outcome measures1. hs-CRP will be measured by a latex-enhanced immunoturbidimetric assay using an ADNIA 1650 Chemistry system 2. TNF-a levels will be measured using a commercially available enzyme-linked immunosorbent assay
3. Chemerin levels will be measured by an enzyme immunoassay kit
4. Levels of fasting glucose, AST, ALT, GGT, TC, TG, HDL-C will be measured using an ADVIA 1650 Chemistry system
5. Physical fitness measured by the 30minute step test, 6-min walk test, chair stand and push up test
6. Quality of life measured by the FACT-C questionnaires
Overall study start date27/08/2011
Completion date31/12/2014

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit75 Years
SexBoth
Target number of participants56 patients in each group
Total final enrolment123
Key inclusion criteria1. Between 18 and 75 years of age
2. Histologically confirmed stage II to III colorectal cancer
3. Completed surgery, radiotherapy, and/or chemotherapy within 4-104 weeks prior to the study
4. ECOG performance status of 0 of 1
5. Not planning extended absences in the 3 months subsequent to enrollment
Key exclusion criteria1. Existing evidence of recurrent or metastatic disease
2. Participation in regular physical activity (purposeful activity of at least a moderate intensity of 200 minutes or more a week)
3. Pregnant or planned to be pregnant within 6 month
Date of first enrolment27/08/2011
Date of final enrolment31/12/2014

Locations

Countries of recruitment

  • Korea, South

Study participating centre

134 Shinchon-Dong, Seodaemun-Gu, Yonsei University
Seoul
120-749
Korea, South

Sponsor information

Yonsei University College of Medicine (South Korea)
University/education

c/o Nam Kyu Kim
Department of Surgery
250 Seongsan-ro
Sedaemun-gu
Seoul
120-752
Korea, South

ROR logo "ROR" https://ror.org/01wjejq96

Funders

Funder type

Government

National Research Foundation of Korea (NRF) (No.2010-0009048)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
한국연구재단이 창의적 연구와, National Research Foundation (South Korea), NRF
Location
Korea, South
Ministry of Health and Welfare - National R & D program for Cancer Control (Republic of Korea), Ref: 1120230

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2017 23/10/2020 Yes No

Editorial Notes

23/10/2020: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.